Introduction {#S1}
============

Macrophages are resident cells found in almost all tissues of the body, where they assume specific phenotypes and develop distinct functions. Tissue macrophages are considered as immune sentinels because of their strategic localization and their ability to initiate and modulate immune responses during pathogenic infection or tissue injury and to contribute to the maintenance of tissue homeostasis ([@B1]--[@B3]). Macrophages were first identified in the late 19th century by Élie Metchnikoff (1845--1916) and designated as large phagocytes ([@B4], [@B5]). Based on their phagocytic activity, macrophages were first classified as cells from the reticuloendothelial system, which also comprised endothelial cells, fibroblasts, spleen and lymphoid reticular cells, Kupffer cells, splenocytes, and monocytes ([@B6]). However, because endocytosis performed by endothelial cells is a process that is distinct from phagocytosis, by the late 1960s a new classification system for mononuclear phagocytic cells as cells from "mononuclear phagocytic system" (MPS) was proposed ([@B7]). The MPS was defined as a group of phagocytic cells sharing morphological and functional similarities, including pro-monocytes, monocytes, macrophages, dendritic cells (DCs), and their bone marrow (BM) progenitors ([@B7]--[@B12]). Although the phagocytic cells play similar roles in orchestrating the immune response and maintaining tissue homeostasis ([@B11]), they represent cell populations that are extremely heterogeneous ([@B13]), and the general classification of mononuclear cells in a unique system is currently under intense discussion ([@B12], [@B14]). In this context, Guilliams et al. suggested a classification of MPS cells based primarily on their ontogeny and secondary on their location, function, and phenotype, promoting a better classification under both steady state and inflammatory conditions ([@B14]).

In the last few years, a complex scenario to describe macrophage origins has been developed ([@B15]--[@B19]), replacing the simplistic view of myeloid precursors giving rise to blood monocytes that, in turn, originate tissue macrophages ([@B20]--[@B22]). For example, resident macrophages from brain, lung, liver, peritoneum, and spleen are not differentiated from monocytes; instead, they are derived from an embryonic precursor and maintained by self-renewal ([@B23]--[@B27]). In addition to resident macrophages, infiltrating monocytes are also found in injured tissues, where they can differentiate into inflammatory macrophages or TNF-α- and inducible nitric oxide synthase (iNOS)-producing (Tip)-DCs ([@B28]). Currently, it is accepted that inflammatory macrophages and tissue-resident macrophages comprise developmentally and functionally distinct populations ([@B3], [@B14], [@B17], [@B18], [@B29]).

Under steady state conditions, some tissues and serous cavities, including lung, spleen, and the peritoneal cavity (PerC), present distinct resident macrophage subpopulations. In the spleen, at least three macrophage subsets are found: red pulp, metalophilic, and marginal zone macrophages ([@B30]). In the PerC, two peritoneal macrophage subsets have been described: large peritoneal macrophage (LPM) and small peritoneal macrophage (SPM) ([@B31]). Mouse peritoneal macrophages are among the best-studied macrophage populations in terms of cell biology, development, and inflammatory responses ([@B24], [@B31]--[@B42]). Peritoneal macrophages play key roles in the control of infections and inflammatory pathologies ([@B43], [@B44]), as well as in the maintenance of immune response robustness ([@B40]). Therefore, this review will discuss recent advances in our understanding of peritoneal macrophage subsets characterization, origin and functions, and the accurate experimental approaches to analyze them.

Identification of Peritoneal Macrophages {#S2}
========================================

Cohn and collaborators introduced the study of peritoneal macrophages ([@B45]--[@B48]). Indeed, a representative portion of the current knowledge regarding macrophage biology, such as their function, specialization, and development stems from studies performed using peritoneal macrophages as a cellular source. However, the existence of two resident macrophage subsets present in the PerC was described recently ([@B31]). These macrophage subsets were designated LPM and SPM according to their size. LPMs and SPMs were initially identified based on their differential expression of F4/80 and CD11b, where LPMs express high levels of F4/80 and CD11b while SPMs show F4/80^low^CD11b^low^ phenotype (Table [1](#T1){ref-type="table"}). CD11b is an integrin that, together with CD18, forms the CR3 heterodimer ([@B13], [@B30], [@B49]), but is not exclusively expressed on macrophages and is found on several others cell types, including polymorphonuclear cells ([@B50], [@B51]), DCs ([@B52]), and at low levels on B lymphocytes ([@B53], [@B54]). F4/80, a 160 kD glycoprotein from the epidermal growth factor (EGF)-transmembrane 7 (TM7) family, is expressed by macrophages in several organs, such as the kidney ([@B55]), BM ([@B56]), epithelium ([@B57]), lung ([@B58], [@B59]), lymphoid organs ([@B60]), and among others ([@B61], [@B62]), and it is not found on fibroblasts, polymorphonuclear cells, and lymphocytes ([@B63]). However, peritoneal eosinophils show low levels of F4/80 ([@B31]) and some macrophage subpopulations exhibit low levels or do not express F4/80, such as white pulp and marginal zone splenic macrophages ([@B30]). Therefore, F4/80 expression levels distinguish macrophage subpopulations, including those residing in the same tissue, such as subsets found in the spleen and PerC ([@B30], [@B31], [@B35]). In this sense, the great majority (approximately 90%) of F4/80^+^CD11b^+^ cells present in the PerC from several mouse strains, including BALB/c, C57BL/6, 129/S6, FVB/N, SJL/J, and RAG^−/−^, express high levels of these molecules and correspond to the LPM subset, whereas the minor SPM subset expresses low levels of these markers ([@B31]).

###### 

**Phenotypic profile of SPMs and LPMs**.

  Surface molecule   LPMs   SPMs
  ------------------ ------ ------
  F4/80              +++    \+
  CD11b              +++    \+
  CD11c              \+     −
  MHC-II             \+     ++
  GR1                \+     −
  Ly6C               −      −
  c-kit              −      −
  CD62L              −      ++
  Dectin-1           \+     ++
  DC-Sign            −      ++
  TLR4               ++     \+
  CD80               ++     \+
  CD86               +++    \+
  CD40               ++     \+
  12/15-LOX          \+     −
  TIM4               \+     −

An accurate evaluation of SPMs and LPMs by flow cytometry and optical microscopy revealed that in addition to the differential expression of CD11b and F4/80, SPMs and LPMs display unique morphologies and phenotypes. LPMs assume the classical morphology described for macrophages after adherence, exhibiting prominent vacuolization and abundant cytoplasm, whereas SPMs display a polarized morphology in culture, presenting dendrites similar to DCs ([@B35]). Moreover, the analysis of a complex panel of cell surface molecules (Table [1](#T1){ref-type="table"}) demonstrated that SPMs express higher levels of MHC-II (IA^b^), dectin-1, and DC-sign endocytic receptors than LPMs. Moreover, half of SPM subset expresses high levels CD62L ([@B31], [@B35], [@B36]). Conversely, LPMs express higher levels of toll like receptor (TLR)-4 and co-stimulatory molecules in comparison to SPMs ([@B31], [@B35], [@B36]).

Given that PerC is a singular compartment where specialized immune cells reside and interact, including macrophages, B cells, DCs, eosinophils, mast cells, neutrophils, T cells, natural killer (NK), and invariant NKT cells ([@B31], [@B32], [@B35], [@B36], [@B64]), the identification of myeloid cells from PerC based on cell surface molecules is still a complex matter, particularly in terms of distinguishing macrophage subsets from DCs and inflammatory monocytes. The expression of 12/15-lipoxygenase (LOX), Tim4, and Ly6B has also been examined to discriminate heterogeneous macrophage subsets in PerC under steady state conditions and during peritonitis ([@B24], [@B37], [@B38], [@B42]). The high expression of 12/15-LOX and Tim4 was observed in peritoneal macrophages, which also express high levels of F4/80 and CD11b, correlating with the phenotype and frequencies observed for LPMs ([@B24], [@B31], [@B37], [@B38], [@B42]). Conversely, 12/15-LOX^-^ cells and SPM share the same CD11b^+^F4/80^low^MHCII^high^ phenotype; however, 12/15-LOX^-^ cells express high levels of CD11c and co-stimulatory molecules, suggesting that 12/15-LOX^-^ cells and SPMs are, at least in part, distinct populations ([@B31], [@B35], [@B37]). Despite similarities in cell morphology and MHC-II expression presented by SPMs and DCs, the possibility that SPMs may be part of the peritoneal DC pool is excluded by the smaller size, the distinct and lack of the CD11b and F4/80 expression presented by DCs and, primarily, by the lower expression of CD11c (HL3 or N418 clones of monoclonal anti-CD11c) on SPMs compared with LPMs or typical peritoneal DCs ([@B31], [@B35]).

Given the cell complexity present in PerC and the importance of the development of efficient strategies to correctly identify macrophage subsets as well as to avoid contamination by other cell populations and misinterpretation of peritoneal macrophage studies, our group has proposed a simple way to identify peritoneal macrophage subsets using a four-color flow cytometry staining panel. From doublet, CD19^high^ and CD11c^high^ discarded selected cell populations; the analysis of F4/80^+^ cells based on MHCII expression defines three distinct subpopulations, F4/80^high^IA^b-neg^, F4/80^low^IA^b-high^, and F4/80^low^IA^b-neg^, which correspond, respectively, to LPMs, SPMs, and granulocytes ([@B35]).

Origin and Development of LPM and SPM {#S3}
=====================================

The theories that explain the origin of macrophages have been completely reformulated in the last few years. The differentiation process of monocytes, macrophages, and DCs that occurs in the BM starts with the earliest progenitor, the hematopoietic stem cell (HSC), and follows the common myeloid progenitor (CMP) and the granulocyte and macrophage progenitor (GMP) ([@B16]). The clonotypic BM-resident precursor differentiated from GMP, termed the macrophage-DC precursor (MDP), expresses high levels of the fractalkine receptor CX3CR1, c-kit, and CD115, and gives rise to circulating blood monocytes, some macrophage populations and a common DC precursor (CDP), but does not originate granulocytes ([@B15], [@B65], [@B66]). The recruitment of monocyte subsets under steady state or inflammatory and pathological conditions depends on particular chemokines and the expression of their counterpart's receptors. The Ly6C^+^ monocyte subset migrates via a CCR2-dependent pathway, whereas Ly6C^-^ appears to migrate in response to CX3CR1 signaling ([@B67]). Under steady state conditions, extravasated monocytes do not contribute to the pool of resident macrophages in many tissues ([@B3], [@B15], [@B16]). In inflammatory settings, the Ly6C^+^ monocyte subset differentiates into inflammatory macrophages and monocyte-derived DCs, such as Tip-DCs ([@B15], [@B16]).

Recent accumulating evidence supports the prenatal origin of tissue-resident macrophages and the idea that they are maintained locally by self-renewal throughout adult life, both in the steady state and after cell turnover, which is predominantly independent of hematopoiesis ([@B17], [@B18], [@B23]--[@B27], [@B29], [@B68], [@B69]). Microglia, Langerhans cells, Kupffer cells, red pulp splenic macrophages, lung, and peritoneal macrophages are originated from embryogenic precursor and proliferative cells maintained by self-renewal ([@B23]--[@B27], [@B69]--[@B71]). Fetal-liver monocytes or primitive macrophages found in the yolk sac, an extraembryonic tissue, have been related with the origin of tissue-resident macrophages. In this context, recent date using yolk sac macrophages depletion and fate-mapping models demonstrated that yolk sac macrophages, which are generated from early erythro-myeloid progenitors (EMPs), are important for development of macrophages in mid-gestation; however in adulthood, only microglia is maintained by these embryogenic precursor ([@B69]). In contrast, fetal monocytes that are derived from late EMPs give rise to tissue-resident macrophages from liver, lung, skin, kidney and spleen ([@B69]). The exception to the origin of resident macrophages is intestinal macrophages, which are continuously repopulated by circulating monocytes ([@B72]).

Understanding the dynamics of maintenance and recruitment of peritoneal macrophages is of particular interest since these cells are involved in physiological as well as pathological processes, such as peritonitis, tumors, and pancreatitis ([@B40], [@B43], [@B44]). Early studies demonstrated that peritoneal macrophages are maintained in PerC through self-renewal in the steady state or under inflammatory conditions ([@B73]--[@B76]). The omentum, a fat tissue that connects the abdominal organs, is also involved in peritoneal macrophage development through the proliferative capacities of omental macrophages ([@B75], [@B76]). The combination of these early observations, which were acquired recently, with the technical advances to correctly identify the peritoneal macrophage subsets has permitted the ontogeny of the peritoneal macrophage subsets to be elucidated ([@B24], [@B31], [@B36], [@B39], [@B40], [@B42]).

Under steady state conditions, LPMs appear to be maintained by self-renewal and independent of hematopoiesis ([@B26], [@B36]), whereas SPMs are originated from circulating monocytes ([@B31], [@B36], [@B40]) (Figure [1](#F1){ref-type="fig"}). Dates from Schulz et al. suggest that, in general, F4/80 expression by tissue macrophages correlated with yolk sac (F4/80^high^) and not hematopoietic (F4/80^low^) progenitors ([@B25]). In the CX3CR1^GFP/WT^ mice, Cain et al. ([@B36]) showed the presence of GFP^+^ cells in DC and SPM pool, but not in the LPM population. Conversely, in the CX~3~CR1CreRosa26R-FGFP mice, which show the active and past expression of CX3CR1, the presence of GFP^+^ cells was found within DC, SPM, and LPM populations. These data indicate that SPMs are short-lived cells, whereas LPMs have a more distant ontogenic relationship with a CX3CR1^+^ progenitor, corroborating the idea that they originate from the yolk sac ([@B36]). However, in chimeric C57BL/6 mice reconstituted with C57BL/6-CD45.1 BM, around 80% of SPMs and more than 70% of LPMs are CD45.1-expressing cells, demonstrating that both peritoneal macrophage subsets differentiate from BM precursors after ablation of peritoneal macrophages induced by irradiation ([@B36]). Data from our group suggest that PerC recruited Ly6C^+^ monocytes could give rise to SPMs during inflammatory conditions ([@B31]). Confirming that SPMs are generated via the differentiation of inflammatory monocytes recruited to PerC, reduced numbers of SPMs are found in the PerC of CCR2^−/−^ mice ([@B40]).

![**Distinct origin of peritoneal macrophage subsets**. SPMs are generated from hematopoietic stem cells (HSC) in the bone marrow (BM) by differentiation of inflammatory blood monocytes ([@B31], [@B40]). However, LPMs appear to be originated from progenitors from yolk sac and independent of hematopoietic progenitors ([@B69]). Local proliferation of LPMs ensures homeostatic maintenance by self-renewal ([@B36]).](fimmu-06-00225-g001){#F1}

The analysis of Ki67 and phosphorylated histone H3 (pHH3 at a discrete stage of mitosis) staining and the quantification of cell cycle and basal DNA content revealed that the number of proliferating F4/80^high^CD11b^high^ cells decreases in 12-week-old mice compared with proliferation capacity of this population in newborn mice (15 days to 4 weeks) ([@B24]). After 12--16 weeks, the number of F4/80^high^CD11b^high^cells in PerC is maintained under a low rate of proliferation, which suggests that the number of F4/80^high^CD11b^high^ peritoneal cells increases during mouse development until PerC acquires sufficient homeostatic cell numbers ([@B24]). Indeed, BrdU-labeled LPM frequencies after a single BrdU pulse were 7 and 15-fold lower than those found in HSC and GMP, respectively. Moreover, the presence of BrdU^+^ LPMs was detectable 14 days after BrdU pulse, suggesting that they are a long-lived population, i.e., maintained at low levels of proliferation ([@B36]). Conversely, the detection of low numbers of proliferating SPMs at 6--10 days after one pulse of BrdU suggests that these cells have a low proliferation rate under steady state conditions and are short-lived cells ([@B36]).

Studies with mice deficient in CCAAT/enhancer binding protein (C/EBP)b also support the notion that LPMs and SPMs represent distinct ontogenies, because in the absence of this transcription factor, PerC did not contain LPMs and exhibited increased numbers of SPMs ([@B36]). Interestingly, adoptively transferred SPMs differentiated into LPMs in Cebpb^−/−^ mice. However, in control mice that have normal numbers of LPMs, only a small frequency of transferred SPMs acquired the F4/80^hi^MHCII^low^CD93^+^ phenotype of LPMs. Based on these results, the authors proposed that under physiological conditions, SPMs appear to contribute in only a small way to generate LPMs, but SPMs could be involved in the maintenance of LPMs in situations where this pool has been greatly reduced, such as under inflammatory conditions or following radiation ablation ([@B36]). These data are consistent with the findings of Yona et al. ([@B26]), which demonstrated the presence of monocyte-derived cells in the LPM compartment 8 weeks after the i.p. injection of thioglycollate. Together with LPMs, a subset of proliferating BM-derived inflammatory macrophage has also been associated with self-renewal mechanisms during the resolution of peritonitis induced by zymosan and thioglycollate ([@B42]). Conversely, LPMs do not seem to contribute to the SPM pool, even during inflammation. Our group demonstrated that adoptively transferred CFDA-SE-labeled LPMs 1 h after LPS stimulation retained its phenotype, and no CFDA-SE^+^ cells were found in the SPM compartment until 2 days after stimulation ([@B31]).

In the last year, a great advance in the understanding of the transcriptional control of peritoneal macrophages provided novel insights into this scenario ([@B39], [@B40]). The zinc finger transcription factor GATA-binding protein 6 (GATA6) appears to regulate the majority of peritoneal macrophage-specific genes (PMSGs). Of note, GATA6 is selectively expressed by LPMs ([@B40]). Accordingly, the number of LPMs were greatly reduced in peritoneal lavages from GATA6-KO^mye^ and Mac-GATA6 KO mice, which have a GATA6 deficiency in all myeloid cells or only in the macrophage lineages, respectively ([@B39], [@B40]). Interestingly, retinoic acid (RA) is the extracellular factor that regulates GATA-6-specific gene expression in LPMs, because vitamin A depleted (VAD; the RA precursor) mice exhibited a decrease in GATA6 expression and LPM numbers ([@B40]). Moreover, the stimulation of peritoneal macrophages from VAD mice with all-trans RA restored the expression of GATA-6 and many PMSGs at levels found in peritoneal macrophages from control mice. In addition to the regulation of gene expression profiling in peritoneal macrophages, GATA-6 appears to be involved in the control of the proliferation, survival, and metabolism of these cells ([@B39], [@B77]). GATA-6-deficient macrophages demonstrate an altered proliferation state during peritonitis ([@B39]). Moreover, Lyz2-Cre × GATA6^(flox/flox)^ mice also exhibit reduced numbers of peritoneal macrophages, which could be explained by the perturbation in their metabolism, culminating in the high frequency of cell death found in this compartment ([@B77]). Despite great contributions to our understanding in the involvement of GATA-6 in peritoneal macrophage development, metabolism, self-maintenance, and survival, the existence of distinct pathways that could govern the transcriptional regulation of SPMs remains largely unknown.

In addition to transcriptional regulation, signaling factors derived from the microenvironment also play an essential role in promoting the development and phenotype of tissue-resident macrophages. For example, TGF-β1 signaling is required for the development of the microglia population and to regulate a microglia expression program through the Smad tissue factors ([@B78]--[@B80]). Heme has been shown to induce Spi-c, a transcription factor important for red pulp macrophage development ([@B81], [@B82]). Finally, in PerC, omentum-derived RA promotes the expression of GATA-6 in the LPM subset, determining its localization and functions ([@B40]), even if the factors that maintain the SPM pool under steady state conditions still remain to be elucidated.

Dynamics and Function of Peritoneal Macrophage Subsets {#S4}
======================================================

Mouse PerC is a compartment where many cell types co-habitat and interact, similar to the secondary lymphoid organs. In addition, PerC is a unique body compartment that contains B-1 cells ([@B83]). Under steady state conditions, the peritoneal cells comprise LPMs, SPMs, B-1 cells, conventional B-2 cells, T cells, NK cells, DCs, and granulocytes (mostly eosinophils) ([@B31], [@B35]). B1 cells constitute the majority of the PerC cell population, whereas the SPM and LPM frequencies represent 30--35% of total peritoneal cells ([@B31], [@B35]) (Figure [2](#F2){ref-type="fig"}A). However, after inflammatory or infectious stimuli, there is a dramatic alteration in cell numbers and the frequencies of each of PerC cell subpopulation. With regard to the myeloid compartment, modifications in PerC cell composition include the disappearance of LPMs, increases in SPM frequency and numbers, and a massive recruitment of inflammatory monocytes ([@B24], [@B31], [@B35], [@B36], [@B40]) (Figure [2](#F2){ref-type="fig"}B).

![**Summary of the dynamic of peritoneal macrophage subsets**. **(A)** Under homeostatic conditions, peritoneal macrophages comprise two subsets LPMs and SPMs ([@B31]). LPMs, which are the major peritoneal macrophage population, appear to be responsible for phagocytosis of apoptotic cell and tissue repair ([@B36]). **(B)** At the outset of inflammation, the myeloid compartment is modified in general by disappearance of LPMs, increase of SPMs numbers, and monocytes influx ([@B31], [@B35], [@B36], [@B40]). The changes in the myeloid cells from zymosan, *T. cruzi*, and LPS stimulated or thioglicollate-elicited PerC result in the gain of immune state ([@B35], [@B36]). SPMs from zymosan and *T. cruzi* stimulated mice contribute to effector function of PerC through secretion of high levels of NO and presence of IL-12-producing cells ([@B35]). In response to LPS *in vivo*, SPMs produce several inflammatory cytokines, such as IL-12, MIP-1α, TNF-α, and RANTES, whereas LPMs produce enhanced amounts of G-CSF, GM-CSF, and KC ([@B36]). LPMs, which migrate to omentum by a retinoic acid and GATA-6-dependent way in response to *in vivo* LPS stimulation or vitamin-A deprivation, return to PerC and appear to be correlated with GALT-independent and TGF-β2-dependent IgA production by B-1 cells in the intestine ([@B40]).](fimmu-06-00225-g002){#F2}

The "macrophage disappearance reaction" (MDR) in PerC has been extensively described during delayed-type hypersensitivity (DTH) and acute inflammatory processes ([@B84]). MDR has been associated with cell death, emigration to draining lymph nodes, or adherence of macrophages to structural tissues. LPMs are the unique peritoneal macrophage subset that disappears from PerC, which is attributed not to cell death but rather to their migration to the omentum ([@B31], [@B40]). LPM disappearance in response to inflammatory stimuli is accompanied by an increase in SPM and inflammatory monocyte numbers ([@B24], [@B31], [@B35], [@B36], [@B40]) (Figure [2](#F2){ref-type="fig"}B), and has been correlated with the renewal and improvement of immune conditions of the PerC ([@B35]). Adherent peritoneal cells from naive mice, which are composed primarily of LPM, exhibit a high frequency of cells stained for β-galactosamine (β-gal), a senescence marker ([@B85]--[@B87]). These cells are unable to secrete NO in response to LPS challenge ([@B35]). In contrast, adherent peritoneal cells from *Trypanosoma cruzi* or zymosan-stimulated mice in which the main cell population constitutes SPMs and monocytes (F4/80^low^MHCII^int^Ly-6C^+^), respectively, display a significant reduction in the frequency of β-gal-positive cells and secrete high levels of NO in response to LPS ([@B35]). The frequency of IL-12-producing cells after *in vitro* LPS plus IFN-γ stimulation was also higher within myelo-monocytic cells from mice exposed to zymosan and *T. cruzi* than the frequencies of IL-12-producing cells found in unstimulated mice ([@B35]). In response to *Staphylococcus epidermidis* cell-free (SES) supernatant *in vivo* stimulation, F4/80^low^CD11b^+^ cells (consisting of SPMs and DCs) produced enhanced levels of IL-1β, IL-1α, TNF-α, and IL-12 in the presence or absence of subsequent SES treatment ([@B37]). In contrast, the supernatants of adherent cells from naïve mice treated with SES were found to contain high levels of MCP-1, MCP-1α, MIP-1β, and G-CSF ([@B37]). It is important to note that 4 days after thioglycollate injection, peritoneal cells, an extensively studied cell population ([@B88]--[@B91]), also consist primarily of SPMs and inflammatory monocytes ([@B31], [@B40]). The increase in SPM numbers and the influx of inflammatory monocytes that will give rise to SPMs greatly contribute to the improvement of the capacity of PerC to deal with inflammatory stimuli. Indeed, although neither SPMs nor LPMs produce significant levels of pro- or anti-inflammatory cytokines under steady state conditions ([@B35]--[@B37]), SPMs appear to develop a pro-inflammatory profile in response to *in vitro* stimuli. SPMs produced high levels of TNF-α, MIP-1α, and RANTES in response to LPS, whereas LPMs were the unique population that produced abundant levels of G-CSF, GM-CSF, and KC in response to the same stimulus ([@B36]) (Figure [2](#F2){ref-type="fig"}B).

The NO secretion and pro-inflammatory cytokine production are the most important functions of activated macrophages by inflammatory stimulation and assigns the M1 profile ([@B13], [@B34], [@B92]--[@B97]). The functional profile of peritoneal macrophages was previous studied by our group and others ([@B33], [@B34]). Peritoneal macrophages from Th1-prone mouse strains (C57BL/6 and B10.A) are easily activated to produce NO in response to rIFN-γ or LPS, characterizing the M1 profile. In contrast, macrophages from Th2-prone mouse strains (BALB/c and DBA/2) exhibit a weak NO response as a consequence of high levels of spontaneously secreted TGF-β1 ([@B34]). Moreover, the cells from C57BL/6 IL-12p40-deficient mice have a bias toward the M2 profile, indicating that IL-12 is required for M1 polarization of peritoneal macrophages ([@B33]). Although LPMs from naïve mice can produce NO after *in vitro* LPS stimulation, SPMs produce higher levels of NO than LPMs following *in vivo* LPS stimulation. The NO secretion by LPMs was also detected by flow cytometry in *Escherichia coli* inoculated mice ([@B31]), whereas nitrite was not produced *in vitro* by LPS-stimulated adherent peritoneal cells from control mice, which is composed mainly by LPMs ([@B35]). In addition, adherent cells obtained 48 h after *T. cruzi* infection, which are mostly composed by SPMs, were the unique source of NO without *in vitro* subsequent challenge with LPS ([@B35]). In resume, the SPM and LPM subsets cannot be accommodated in the M1/M2 framework considering the NO secretion. However, considering phagocytic assays, SPMs appear to develop an efficient profile to control infections as M1 macrophages, whereas LPMs assume a role in the maintenance of PerC physiological conditions as M2 or alternative macrophages. Despite the preserved phagocytic ability of LPMs, higher numbers of zymosan and *E. coli* were found inside of SPMs at early time points after i.p. injection ([@B31], [@B35]). Conversely, at 1 h after challenge, LPMs appear to present a higher phagocytic index of apoptotic thymocytes in comparison to SPMs ([@B36]) (Figure [2](#F2){ref-type="fig"}A).

In addition, it was recently demonstrated that LPMs have a unique ability to induce gut-associated lymphoid tissue (GALT)-independent IgA production by peritoneal B-1 cells ([@B40]) (Figure [2](#F2){ref-type="fig"}B). RA and TGF-β2 are the most critical factors to induce IgA class switching, and the production of TGF-β2 is regulated by the *Tgfb2* and *Ltbp1* genes, which are expressed by LPMs in a GATA-6-dependent manner. This process is regulated by the abundant presence of RA in the omentum, which is responsible for the induction of GATA-6 expression in LPMs that migrates to this tissue. The dynamic of LPM migration between the PerC and the omentum after the stimulation of PerC is correlated with their disappearance and the return to basal numbers of LPMs later after stimulation with LPS, zymosan, and thioglycollate ([@B24], [@B31], [@B35], [@B36], [@B39], [@B40]). This observation suggests that LPMs can return to PerC to resolve an infectious or inflammatory process. Therefore, the presence of two specialized macrophage subsets in PerC is crucial to maintain the health of this compartment under different situations.

Concluding Remarks {#S5}
==================

Peritoneal macrophages represent one of the most studied macrophage populations. However, the existence of two phenotypically and functionally distinct subsets, LPMs and SPMs, residing in the PerC was recognized recently ([@B31]). In the last year, great advances in our understanding of the transcriptional regulation of peritoneal macrophages have brought novel insights into the identification of LPMs and SPMs ([@B39], [@B40]). GATA-6, an LPM-restricted transcription factor, regulates many PMSGs, including those related to the maintenance of LPMs in PerC ([@B40]) and those that determine their function ([@B40]), metabolism, proliferation, and cell survival ([@B39], [@B77]). Under steady state conditions, LPMs appear to originate independently from hematopoietic precursors and retained the ability to proliferate *in situ*, maintaining physiological numbers ([@B26], [@B36]). Conversely, SPMs appear to originate from circulating monocytes ([@B31], [@B36], [@B40]), and their numbers increase remarkably under inflammatory conditions. Of note, SPMs together with their precursor, the inflammatory monocyte population, are the major myeloid populations present in elicited PerC, and are an excellent resource to study the biology of inflammatory macrophages. SPMs and LPMs exhibit specialized functions in the PerC, where SPMs present a pro-inflammatory functional profile, and LPMs appear to have a role in the maintenance of PerC physiological conditions. Moreover, the particular interactions between macrophage subsets and other peritoneal cell populations appear to play crucial roles in PerC immune state. Although the consequences of the crosstalk between SPMs and peritoneal T and B lymphocytes remain to be clarified, LPMs are required for GALT-independent and RA-dependent IgA production by peritoneal B-1 cells ([@B40]). Finally, the elucidation of the influence of soluble factors and the microbiota on the maintenance of LPM/SPM ratios in PerC, and the role of these subsets in the systemic immune response are the future challenges for this field.
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